Journey Medical (DERM) Assets Average (2021 - 2026)

Journey Medical's Assets Average history runs 6 years deep, the most recent figure standing at $93.1 million for Q1 2026.

• Quarterly Assets Average rose 12.66% year-over-year to $93.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.1 million (up 12.66% YoY) and the FY2025 annual result came in at $87.4 million, up 11.29% from the prior year.
• Assets Average was $93.1 million for Q1 2026 at Journey Medical, up from $89.9 million in the prior quarter.
• Across five years, Assets Average topped out at $117.2 million in Q2 2022 and bottomed at $64.6 million in Q3 2024.
• A 5-year average of $86.6 million and a median of $83.1 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average plunged 38.79% — and 2025, when it climbed 28.72%.
• Journey Medical's Assets Average stood at $106.7 million in 2022, then slumped by 33.07% to $71.4 million in 2023, then grew by 1.06% to $72.1 million in 2024, then gained by 24.6% to $89.9 million in 2025, then advanced by 3.53% to $93.1 million in 2026.
• Business Quant data shows DERM's Assets Average at $93.1 million in Q1 2026, $89.9 million in Q4 2025, and $83.2 million in Q3 2025.